🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A clinical study to evaluate a treatment with two drugs, named Ofatumumab a...
Status
Completed
Location
Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia
Start Date
2015-10
Trial ID
NCT02388048
Treatments Being Tested
A prospective, open-label, multicentre phase-II trial to evaluate the effic...
Status
Completed
Location
German CLL Study Group
Start Date
2016-02-04
Trial ID
NCT02689141
Treatments Being Tested
The purpose of the study is to evaluate whether treatment with ibrutinib as...
Status
Completed
Location
Site #408
Start Date
2012-06
Trial ID
NCT01578707
Treatments Being Tested
Based on the promising results obtained with ibrutinib as single agent, the...
Status
Unknown
Location
Hospital Son Espases (Son Dureta)
Start Date
2017-09-07
Trial ID
NCT03280160
Treatments Being Tested
This phase I trial studies the side effects and best dose of buparlisib whe...
Status
Terminated
Location
Emory University/Winship Cancer Institute
Start Date
2016-01
Trial ID
NCT02614508
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of a fixe...
Status
Completed
Location
The Ohio State University
Start Date
2010-12
Trial ID
NCT01217749
Treatments Being Tested